Filter
754
Filtered Results: 754
Text search:
oxygen
therapy
Featured
Recommendations
148
New Publications
148
Language
Document type
No document type
344
Guidelines
212
Studies & Reports
69
Manuals
63
Fact sheets
15
Training Material
13
Infographics
13
Strategic & Response Plan
12
Online Courses
4
Situation Updates
3
Brochures
2
Resource Platforms
2
Videos
2
Countries / Regions
India
75
Kenya
27
Global
24
South Africa
22
Rwanda
21
Ethiopia
16
Tanzania
14
Nigeria
13
Nepal
13
Zambia
13
Liberia
12
Uganda
12
Russia
11
Bangladesh
10
Latin America and the Carribbean
9
Philippines
8
Namibia
8
Western and Central Europe
8
Africa
8
Sierra Leone
7
Ghana
7
Syria
7
Indonesia
7
Malawi
7
Brazil
6
Ukraine
5
Eswatini/ Swaziland
4
Eastern Europe and Central Asia
4
Zimbabwe
3
Haiti
3
Somalia
3
South Sudan
3
Germany
3
Myanmar / Burma
3
West and Central Africa
3
Middle East and North Africa
3
South–East Asia Region
3
Senegal
2
USA
2
Cambodia
2
Mozambique
2
Angola
2
Yemen
2
East and Southern Africa
2
Asia
2
Eastern Europe
2
Vietnam
2
United Kingdom
2
Congo, Democratic Republic of
1
Guinea-Bissau
1
Saudi Arabia
1
Cameroon
1
Iraq
1
Afghanistan
1
Turkey
1
Chad
1
Gambia
1
China
1
Papua New Guinea
1
Argentina
1
North Macedonia
1
Hungary
1
Botswana
1
Libya
1
Lesotho
1
Other region
1
Fiji
1
Solomon Islands
1
Poland
1
Timor Leste/ East Timor
1
Bulgaria
1
Romania
1
Moldova
1
Slovakia
1
France
1
Portugal
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
330
Clinical Guidelines
124
Women & Child Health
75
Public Health
37
Key Resources
13
Capacity Building
11
Pharmacy & Technologies
9
Toolboxes
COVID-19
154
Caregiver
54
NCDs
34
Mental Health
27
Pharmacy
26
TB
24
Rapid Response
23
Ebola
17
Conflict
16
NTDs
16
Disability
15
HIV
12
AMR
9
Specific Hazards
7
Planetary Health
6
Refugee
5
Cholera
4
Health Financing Toolbox
4
Global Health Education
3
Natural Hazards
2
Polio
1
Zika
1
This document puts forward the joint position and vision of an expert, global, multistakeholder working group on implementing Kangaroo Mother Care (KMC) for all preterm or low birth weight (LBW) infants as the foundation for small and/or sick newborn care within maternal, newborn, and child health p...
The Regional Action Framework for Noncommunicable Disease Prevention and Control provides a unified vision of objectives and recommended actions to combat the noncommunicable disease (NCD) epidemic in the Western Pacific Region. Implementation should be supported by cross-sectoral coordination...
COVID-19 has altered health sector capacity in low-income and middle-income countries (LMICs). Cost data to inform evidence-based priority setting are urgently needed. Consequently, in this paper, we calculate the full economic health sector costs of COVID-19 clinical management in 79 LMICs under di...
This results report for the biennium 2020–2021 presents the progress towards the triple billion targets, outcomes and outputs, based on the GPW 13 results framework and indicators. It uses structured methodologies, both quantitative and qualitative, for measuring and analysing the achievements and...
Six months after its launch on 24 April, the Access to COVID-19 Tools (ACT) Accelerator has already delivered concrete results in speeding up the development of new therapeutics, diagnostics, and vaccines. Now mid-way through the scale-up phase, the tools we need to fundamentally change the course o...
Many features of the environment have been found to exert an important influence on cardiovascular disease (CVD) risk, progression, and severity. Changes in the environment due to migration to different geographic locations, modifications in lifestyle choices, and shifts in social policies and cultu...
Atherosclerotic lower-extremity peripheral artery disease (PAD) is increasingly recognized as an important cause of cardiovascular morbidity and mortality that affects more than 230 million people worldwide. Traditional cardiovascular risk factors, including advanced age, smoking, and diabetes, are ...
WHO has published the first-ever guidance on the clinical management of diphtheria. The only previously available guidance was an operational protocol. The new guidance followed the rigorous process for developing guidance at WHO.
It addresses the use of Diphtheria Antitoxin (DAT) in the treatmen...
The incidence and mortality of cardiovascular diseases (CVDs) in low and middle income countries (LMICs) have been increasing, while access to CVDs medicines is suboptimal. We assessed selection of essential medicines for the prevention and treatment of CVDs on national essential medicines lists (NE...
The Infection Prevention and Control (IPC) Guidelines aim to support healthcare workers improve quality and safety health care. The Guidelines further aim to promote and facilitate the overall goal of IPC by providing evidence-based recommendations on the critical aspects of IPC, focusing on the fun...
In this document, the Inter-American Committee of Cardiovascular Prevention and Rehabilitation, together with the South
American Society of Cardiology, aimed to formulate strategies, measures, and actions for cardiovascular disease prevention
and rehabilitation (CVDPR). In the context of the imple...
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, with cases projected to rise from 537 million in 202...
Patients with diabetes are at increased risk of developing cardiovascular disease (CVD) with its manifestations of coronary artery disease (CAD), heart failure (HF), atrial fibrillation (AF), and stroke, as well as aortic and peripheral artery diseases. In addition, diabetes is a major risk factor f...
Cardiovascular diseases (CVDs) are a growing public health problem in Ghana and other African countries. Strokes and other CVDs have become a leading cause of death due to increasing risk factors such as hypertension. According to the Global Burden of Disease study (GBD), ischaemic heart disease was...
The Kenya Health Policy 2014-2030 aims at attaining the highest possible standard of health in a manner responsive to the health needs of our population. One of the major policy directions towards realizing the intentions of this policy is to halt and reverse the
rising burden of non-communicable d...
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, with cases projected to rise from 537 million in 202...
The "WHO Package of Essential Noncommunicable (PEN) Disease Interventions for Primary Health Care" provides a set of cost-effective, evidence-based interventions to address noncommunicable diseases (NCDs) such as cardiovascular diseases, diabetes, chronic respiratory diseases, and cancers. Designed ...
This study identifies barriers and provides recommendations to improve asthma care in children across sub-Saharan Africa, where qualitative data is lacking despite high rates.
Asthma is the most common noncommunicable disease in children, and among the most common in adults. According to the most recent estimates from the Global Asthma Network Phase I study, around one in 10 children and adults have symptoms of asthma and one in 20 school-aged children have severe asthma ...
Chronic respiratory diseases, such as asthma and
chronic obstructive pulmonary disease, kill more than
four million people every year and affect hundreds
of millions more. These diseases erode the health
and well-being of the patients and have a negative
impact on families and societies. Women ...
